Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Paclitaxel/Carboplatin in Carcinoma of Unknown Primary (PACET-CUP)
NCT00894569Phase 2Unknown
- Sponsor
- Heidelberg University
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in carcinoma of unknown primary (CUP), sponsored by Heidelberg University. Status: unknown.
02
Drugs
cetuximab
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00894569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894569.